Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
09:11:07 EDT Thu 25 Apr 2024
Enter Symbol
or Name
USA
CA



Q:NRXP - NRX PHARMACEUTICALS INC - http://www.norexxpl.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NRXP - Q8.22.95·3.122.13.120.305    12.00  2.2108:18:51Apr 1815 min RT 2¢

Recent Trades - All 5 today
Time ETExPriceChangeVolume
08:18:51Q3.150.0361
08:00:03Q3.150.0325
07:06:22Q3.05-0.0715
07:06:22Q3.05-0.0717
07:05:00Q3.12 8
     
     
     
     
     

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2024-04-18 08:32U:NRXPNews ReleaseNRx Pharmaceuticals (NASDAQ:NRXP) Receives Notice from Nasdaq that the Company has Demonstrated Compliance with the Bid Price Requirement
2024-04-18 08:30U:NRXPNews ReleaseNRx Pharmaceuticals, Inc. Announces Pricing of $2.0 Million Underwritten Public Offering of Common Stock
2024-04-17 16:45U:NRXPNews ReleaseNRx Pharmaceuticals, Inc. Announces Proposed Underwritten Public Offering of Common Stock
2024-04-17 08:30U:NRXPNews ReleaseNRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Announces New Data on NRX-101 Demonstrating No Damage to Intestinal and Vaginal Flora in Validated Rodent Models Compared to Standard Antibiotics: Potential Implications for Avoidance of C. Difficile infections
2024-04-15 08:30U:NRXPNews ReleaseNRx Pharmaceuticals (NASDAQ:NRXP) Announces Development of New, Proprietary Formulation of HTX-100 (IV Ketamine)
2024-04-08 08:30U:NRXPNews ReleaseNRx Pharmaceuticals (NASDAQ:NRXP) Announces Data-Lock of Phase 2b/3 Trial of NRX-101 in Suicidal Treatment Resistant Bipolar Depression
2024-04-01 08:28U:NRXPNews ReleaseNRx Pharmaceuticals (Nasdaq:NRXP) Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
2024-03-28 08:03U:NRXPNews ReleaseNRx Pharmaceuticals (NASDAQ:NRXP) Reports Preliminary Fourth Quarter and Full Year 2023 Financial Results and Provides Year End Highlights
2024-03-28 08:00U:NRXPNews ReleaseNRx Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing
2024-03-26 16:03U:NRXPNews ReleaseUPDATE: NRx Pharmaceuticals (NASDAQ: NRXP) to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024